Contribution of ultrasonographic examination to the prenatal detection of trisomy 21: Experience from 19 European registers

Annales de Genetique

Volumn 47, Issue 4, 2004, Pages 373-380

  Wellesley, D ^a   De Vigan, C ^b   Baena, N ^c   Cariati, E ^d   Stoll, C ^e   Boyd, P A ^f   Clementi, M ^g  

^a PRINCESS ANNE HOSPITAL   (United Kingdom)

^b Paris Registry Congenital A   (France)

^c Servicio de Oncología Médica   (Spain)

^d Genet Clin Epidemiologica O   (Italy)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g Genetica Clinica e Epidemiologica   (Italy)

Author keywords

Birth defect; Congenital anomalies; Down syndrome; Prenatal diagnosis; Trisomy 21; Ultrasound

Indexed keywords

AMNIOCENTESIS; ARTICLE; BLOOD ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; LITHUANIA; MAJOR CLINICAL STUDY; MATERNAL AGE; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; TRISOMY 21;

DOWN SYNDROME; EUROPE; FEMALE; GESTATIONAL AGE; HUMANS; MASS SCREENING; MATERNAL AGE; PREGNANCY; PREGNANCY OUTCOME; REGISTRIES; ULTRASONOGRAPHY, PRENATAL;

EID: 9644270353     PISSN: 00033995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anngen.2004.09.005     Document Type: Article

References (19)

1. Royal College of Obstetricians and Gynaecologists Report of the working party on biochemical markers and the detection of Down's syndrome 1993 RCOG Press London
2. D.T. Howe, R. Gornall, D. Wellesley, T. Boyle, and J. Barber Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans BMJ 320 2000 606 610
3. D. Wellesley, T. Boyle, J. Barber, and D.T. Howe Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in a single health region BMJ 325 2002 15 17
4. H. Grandjean, D. Larroque, and S. Levi The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study Am. J. Obstet. Gynecol. 181 1999 446 454
5. P.A. Boyd, P. Chamberlain, and N.R. Hicks 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK Lancet 352 1998 1577 1581
6. C. Stoll, B. Dott, Y. Alembik, and M.P. Roth Evaluation of routine prenatal diagnosis by a registry of congenital anomalies Prenat. Diagn. 15 1995 791 800
7. C. De:Vigan, N. Baena, E. Cariati, M. Clementi, and C. Stoll Contribution of ultrasonographic examination to the prenatal detection of chromosome abnormalities in 19 centres across Europe Ann. Genet. 44 2001 209 217
8. M. Clementi, C. Stoll The Euroscan Study Ultrasound Obstet. Gynecol. 18 2001 297 300
9. R.J. Snijders, L.D. Platt, N. Greene, D. Carlson, D. Krakow, and K. Gregory Femur length and trisomy 21: impact of gestational age on screening efficiency Ultrasound Obstet. Gynecol. 16 2000 142 145
10. R. Maymon, M. Betser, E. Dreazen, A. Padoa, and A. Herman A model for disclosing the first trimester part of an integrated Down's syndrome screening test Clin. Genet. 65 2004 113 119
11. G.R. De:Vore Trisomy 21: 91% detection rate using second-trimester ultrasound markers Ultrasound Obstet. Gynecol. 16 2000 133 141
12. B.R. Benacerraf Should sonographic screening for fetal Down syndrome be applied to low risk women? Ultrasound Obstet. Gynecol. 15 2000 451 455
13. P.A. Boyd, D.G. Wellesley, H.E. De:Walle, R. Tenconi, S. Garcia-Minaur, and G.R. Zandwijken Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe J. Med. Screen. 7 2000 169 174
14. N.J. Wald, A. Kennard, J.W. Densem, H.S. Cuckle, T. Chard, and L. Butler Antenatal maternal serum screening for Down's syndrome: results of a demonstration project BMJ 305 1992 391 394
15. A. Drugan, M.P. Johnson, and M.I. Evans Ultrasound screening for fetal chromosome anomalies Am. J. Med. Genet. 90 2000 98 107
16. H. Cuckle Time for total shift to first-trimester screening for Down's syndrome Lancet 358 2001 1658 1659
17. E.Y. Cheng, D.A. Luthy, A.M. Zebelman, M.A. Williams, R.E. Lieppman, and D.E. Hickok A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol Obstet. Gynecol. 81 1993 72 77
18. P.P. Pandya, R.J. Snijders, S.P. Johnson, M. De:Lourdes Brizot, and K.H. Nicolaides Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 1014:weeks of gestation Br. J. Obstet. Gynaecol. 102 1995 957 962
19. C. Stoll, Y. Alembik, B. Dott, and M.P. Roth Impact of prenatal diagnosis on livebirth prevalence of children with congenital anomalies Ann. Genet. 45 2002 115 121